Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RESQU-SARC
NCT04189783Phase 2Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2020
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal bupivacaine in postoperative pain, sponsored by University of Texas MD Anderson Cancer Center. Started Jun 2020; status: active, not recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04189783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04189783.